Unilever PLC (NYSE: UL) is a Consumer Defensive company in the Household & Personal Products industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 21.36 | EPS (ttm) | 3.00 | Insider Own | - | Shs Outstand | 2.15B | Perf Week | -4.17% |
| Market Cap | 138.04B | Forward P/E | 16.85 | EPS next Y | 3.80 | Insider Trans | - | Shs Float | 2.16B | Perf Month | 4.06% |
| Enterprise Value | 167.98B | PEG | 3.71 | EPS next Q | - | Inst Own | - | Short Float | 0.05% | Perf Quarter | 9.15% |
| Income | 6.56B | P/S | 2.56 | EPS this Y | 20.35% | Inst Trans | - | Short Ratio | 0.26 | Perf Half Y | -6.82% |
| Sales | 53.92B | P/B | 6.61 | EPS next Y | 5.33% | ROA | 7.32% | Short Interest | 1.08M | Perf YTD | -2.02% |
| Book/sh | 9.70 | P/C | 20.60 | EPS next 5Y | 5.75% | ROE | 35.40% | 52W High | 74.98 -14.54% | Perf Year | -5.90% |
| Cash/sh | 3.11 | P/FCF | 16.54 | EPS past 3/5Y | -2.42% 3.86% | ROIC | 16.80% | 52W Low | 54.75 17.04% | Perf 3Y | 5.01% |
| Dividend Est. | 2.12 (3.31%) | EV/EBITDA | 13.73 | Sales past 3/5Y | -3.39% -0.30% | Gross Margin | 42.96% | Volatility | 1.36% 1.47% | Perf 5Y | 0.79% |
| Dividend TTM | 2.27 (3.55%) | EV/Sales | 3.12 | EPS Y/Y TTM | 21.09% | Oper. Margin | 26.89% | ATR (14) | 1.44 | Perf 10Y | 22.27% |
| Dividend Ex-Date | Aug 07, 2026 | Quick Ratio | 0.58 | Sales Y/Y TTM | -17.97% | Profit Margin | 12.17% | RSI (14) | 57.04 | Recom | 3.00 |
| Dividend Gr. 3/5Y | 2.79% 1.08% | Current Ratio | 0.74 | EPS Q/Q | 13.41% | SMA20 | 2.53% | Beta | 0.41 | Target Price | 71.00 |
| Payout | 77.15% | Debt/Eq | 1.68 | Sales Q/Q | -9.34% | SMA50 | 6.63% | Rel Volume | 0.94 | Prev Close | 63.80 |
| Employees | 94,912 | LT Debt/Eq | 1.54 | Earnings | Feb 11 | SMA200 | 0.61% | Avg Volume | 4.41M | Price | 64.08 |
| IPO Date | Mar 25, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -5.75% 106.42% | Net Debt/EBITDA | 2.62 | Volume | 4,140,203 | Change | 0.44% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Apr-21-26 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform | |
| Feb-18-26 | Downgrade | DZ Bank | Buy → Hold | |
| Feb-17-26 | Downgrade | Kepler | Buy → Hold | |
| Feb-09-26 | Downgrade | Deutsche Bank | Buy → Hold | |
| Jan-08-26 | Reiterated | BNP Paribas | $71 | |
| Jan-08-26 | Downgrade | Exane BNP Paribas | Outperform → Neutral | |
| Dec-15-25 | Resumed | Morgan Stanley | Overweight | $60 |
| Feb-21-25 | Upgrade | DZ Bank | Hold → Buy | |
| Jan-06-25 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform | |
| Nov-19-24 | Downgrade | Erste Group | Buy → Hold |
Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through four segments: Beauty & Wellbeing, Personal Care, Home Care, and Foods. The Beauty & Wellbeing segment offers hair care, such as shampoo, conditioner, and styling; face, hand, and body moisturizer skin care products; and Prestige Beauty and Wellbeing products. The Personal Care segment provides soap and shower skin cleansing products; and deodorant and oral care, including toothpaste, toothbrush, and mouthwash products. The Home Care segment offers washing powders and liquids, and rinse conditioner fabric care products; and a range of home and hygiene cleaning products. The Foods segment provides cooking aids and mini meals comprising soups, bouillons, and seasonings, as well as mayonnaise and ketchup condiments; and Unilever food solutions. The company provides its products under the AXE, Clear, Cif, Closeup, Comfort, Dermalogica, Domestos, Dove, Dove Men+Care, Hellmann's, Horlicks, Knorr, LUX, Lifebuoy, Liquid I.V., Nexxus, Nutrafol, OMO, Pond's, Paula's Choice, Pepsodent, Radiant, Rexona, Sunlight, Sunsilk, Surf, TRESemmé, and Vaseline brand names. Unilever PLC was founded in 1860 and is headquartered in London, the United Kingdom.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 53,921 | 56,974 | 65,737 | 64,470 | 63,175 | 62,021 | 57,847 | 58,220 | 60,166 | |
| Cost of Goods Sold Incl. D&A | 0 | 30,227 | 0 | 37,240 | 37,760 | 35,785 | 32,712 | 32,596 | 33,873 | |
| Gross Profit | 23,725 | 56,974 | 65,737 | 27,230 | 25,415 | 26,236 | 25,135 | 25,624 | 26,292 | |
| Selling, General and Administrative Excl. Other | 0 | 15,370 | 77 | 16,370 | 15,186 | 14,853 | 13,551 | 13,576 | 14,092 | |
| Research and Development | 0 | 0 | 0 | 1,026 | 955 | 1,002 | 912 | 941 | 1,062 | |
| Other Operating Expense | 41,683 | -48 | 55,490 | -720 | -2,037 | 90 | 1,203 | 1,354 | -3,777 | |
| Operating Income | 10,952 | 10,195 | 10,170 | 10,555 | 11,310 | 10,291 | 9,469 | 9,753 | 14,916 | |
| Interest Expense | 1,200 | 1,110 | 1,210 | 1,163 | 830 | 589 | 802 | 855 | 863 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -68 | 722 | 635 | 710 | 390 | 416 | 452 | 385 | 533 | |
| Net Income Before Taxes | 9,684 | 9,807 | 9,595 | 10,101 | 10,871 | 10,118 | 9,119 | 9,284 | 14,586 | |
| Income Taxes | 3,008 | 2,799 | 2,705 | 2,379 | 2,175 | 2,288 | 2,193 | 2,535 | 3,035 | |
| Consolidated Net Income | 6,562 | 10,682 | 6,214 | 7,017 | 8,037 | 7,154 | 6,365 | 6,300 | 11,057 | |
| Net Income From Continuing Operations | 6,677 | 7,009 | 6,891 | 7,723 | 8,696 | 7,830 | 6,926 | 6,749 | 11,551 | |
| Net Income | 6,562 | 10,682 | 6,214 | 7,017 | 8,037 | 7,154 | 6,365 | 6,300 | 11,057 | |
| EPS (Recurring) | 3.01 | 3.02 | 2.49 | 2.79 | 3.15 | 2.76 | 2.43 | 2.41 | 4.11 | |
| EPS (Basic, Before Extraordinaries) | 3.01 | 3.02 | 2.49 | 2.79 | 3.15 | 2.76 | 2.43 | 2.41 | 4.11 | |
| EPS (Diluted) | 3.00 | 2.92 | 2.48 | 2.77 | 3.14 | 2.74 | 2.42 | 2.40 | 4.11 | |
| EBITDA | 12,238 | 12,993 | 14,072 | 11,961 | 11,127 | 13,462 | 12,973 | 13,307 | 13,379 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 21.36 | 22.38 | 25.77 | 19.71 | 18.03 | 22.08 | 28.11 | 26.86 | 14.33 | |
| Price To Sales Ratio | 2.58 | 2.51 | 2.44 | 2.15 | 2.29 | 2.55 | 3.09 | 2.91 | 2.63 | |
| Gross Margin | 44.00 | 100.00 | 100.00 | 42.24 | 40.23 | 42.30 | 43.45 | 44.01 | 43.70 | |
| Operating Margin | 20.31 | 17.89 | 15.47 | 16.37 | 17.90 | 16.59 | 16.37 | 16.75 | 24.79 | |
| Net Margin | 12.17 | 18.75 | 9.45 | 10.88 | 12.72 | 11.53 | 11.00 | 10.82 | 18.38 | |
| Shares Outstanding | 2,175 | 2,184 | 2,508 | 2,534 | 2,556 | 2,607 | 2,633 | 2,629 | 2,692 | |
| Market Capitalization | 139,374 | 142,834 | 160,136 | 138,331 | 144,925 | 157,906 | 178,965 | 169,255 | 158,397 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |